Safety and tolerability study of sotrovimab (VIR-7831) prophylaxis against COVID-19 infection in immunocompromised individuals with impaired SARS-CoV-2 humoral immunity

Bibliographic Details
Title: Safety and tolerability study of sotrovimab (VIR-7831) prophylaxis against COVID-19 infection in immunocompromised individuals with impaired SARS-CoV-2 humoral immunity
Authors: Isabel H. Gonzalez-Bocco, Katherine Beluch, Alyssa Cho, Chloe Lahoud, Fabiola A. Reyes, Dimitrios G. Moshovitis, Gillian M. Unger-Mochrie, Wei Wang, Sarah P. Hammond, Jennifer Manne-Goehler, Sophia Koo
Source: Pilot and Feasibility Studies, Vol 9, Iss 1, Pp 1-10 (2023)
Publisher Information: BMC, 2023.
Publication Year: 2023
Collection: LCC:Medicine (General)
Subject Terms: COVID-19, Immunocompromised Host, Pre-exposure prophylaxis, Antibodies, Monoclonal, Humanized, Immunity, Medicine (General), R5-920
More Details: Abstract Background Multiple vaccines have been approved since August 2021 to prevent infection with SARS-CoV-2; however, 20–40% of immunocompromised people fail to develop SARS-CoV-2 spike antibodies after COVID-19 vaccination and remain at high risk of infection and more severe illness than non-immunocompromised hosts. Sotrovimab (VIR-7831) is a monoclonal neutralizing antibody that binds a conserved epitope on the SARS-CoV-2 spike protein. It is neither renally excreted nor metabolized by P450 enzymes and therefore unlikely to interact with concomitant medications (e.g., immunosuppressive medications). In this open-label feasibility study protocol, we will define the optimal dose and dosing interval of sotrovimab as pre-exposure prophylaxis for immunocompromised individuals as well as its safety and tolerability in this population specifically. Methods We will enroll 93 eligible immunocompromised adults with a negative or low-positive (
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2055-5784
Relation: https://doaj.org/toc/2055-5784
DOI: 10.1186/s40814-023-01325-y
Access URL: https://doaj.org/article/ad657617d462466bb5be8c3ad95de933
Accession Number: edsdoj.657617d462466bb5be8c3ad95de933
Database: Directory of Open Access Journals
More Details
ISSN:20555784
DOI:10.1186/s40814-023-01325-y
Published in:Pilot and Feasibility Studies
Language:English